Brucella abortus is a zoonotic Gram-negative pathogen that causes brucelosis in ruminants and humans. Toll-like receptors (TLRs) recognize Brucella abortus and initiate antigen-presenting cell activities that affect both innate and adaptive immunity. In this study, we focused on recombinant Brucella cell-surface protein 31 (rBCSP31) to determine its effects on mouse macrophages. Our results demonstrated that rBCSP31 induced TNF-a, IL-6 and IL-12p40 production, which depended on the activation of mitogen-activated protein kinases (MAPKs) by stimulating the rapid phosphorylation of p38 and JNK and the activation of transcription factor NF-kB in macrophages. In addition, continuous exposure (.24 h) of RAW264.7 cells to rBCSP31 significantly enhanced IFN-c-induced expression of MHC-II and the ability to present rBCSP31 peptide to CD4 1 T cells. Furthermore, we found that rBCSP31 could interact with both TLR2 and TLR4. The rBCSP31-induced cytokine production by macrophages from TLR2 2/2 and TLR4 2/2 mice was lower than that from C57BL/6 macrophages, and the activation of NF-kB and MAPKs was attenuated in macrophages from TLR2 2/2 and TLR4 2/2 mice. In addition, CD4 1 T cells from C57BL/6 mice immunized with rBCSP31 produced higher levels of IFN-c and IL-2 compared with CD4 1 T cells from TLR2 2/2 and TLR4 2/2 mice. Macrophages from immunized C57BL/6 mice produced higher levels of IL-12p40 than those from TLR2 2/2 and TLR4 2/2 mice. Furthermore, immunization with rBCSP31 provided better protection in C57BL/6 mice than in TLR2 2/2 and TLR4 2/2 mice after B. abortus 2308 challenge. These results indicate that rBCSP31 is a TLR2 and TLR4 agonist that induces cytokine production, upregulates macrophage function and induces the Th1 immune response.
INTRODUCTION
Brucella abortus is a zoonotic Gram-negative pathogen that causes abortion and infertility in ruminants. In humans, patients infected with B. abortus present primarily with flu-like symptoms, i.e., fever, chills, sweating, headaches, arthralgia and myalgia. 1 Brucella is a facultative intracellular bacterial parasite; the pathogenesis of brucellosis and the nature of the protective immune response are closely related to this property. 2 Infection with B. abortus potently activates both the innate and adaptive parts of the immune system, leading to a proinflammatory response that favors the T-helper 1 (Th1) responses. 3, 4 Although both antibody (Ab)-and cell-mediated immune responses can influence the course of infection with Brucella, the latter are primary for clearance of intracellular bacteria.
Macrophages are an early barrier for defense against Brucella. They phagocytose and degrade invading microorganisms and thus actively participate in innate immunity. Additionally, after processing microorganisms within intracellular compartments, they promote the adaptive immune response by presenting peptides with major histocompatibility complex (MHC) to T lymphocytes.
Detection of microbes by Toll-like receptors (TLRs) is a critical step in activation of the innate immune response and is essential for robust priming of the adaptive immune response. 6, 7 Recent studies have demonstrated that both TLR2 and TLR4 recognize bacterial components among TLR family members. TLR2 and TLR4 are mainly required for signaling initiated by multiple ligands from Gram-negative and -positive bacteria, mycobacteria, spirochetes and mycoplasmas, such as lipoteichoic acid, peptidoglycans, lipoproteins and certain types of lipopolysaccharide (LPS). [8] [9] [10] [11] [12] [13] [14] [15] [16] Most TLRs use myeloid differentiation factor 88 (MyD88) with the exception of TLR3, which exclusively recruits Toll-IL-1 resistance domain-containing adaptor-inducing IFN-b (TRIF). 17 TLR4 is the only member of the TLR family that exploits both MyD88 and TRIF to induce the downstream targets of the signaling cascade. 18, 19 In TLR signaling pathway, MyD88 is crucial for the activation of transcription factor NF-kB and thus for the production of pro-inflammatory cytokines such as TNF-a [20] [21] [22] and antimicrobial peptides that eventually help contain and clear the infection. 23 When bound to TLR, MyD88 recruits IL-1R-associated kinase protein 1 (IRAK-1), IRAK-4 and TNF receptor-associated factor 6 (TRAF6) to form a receptor complex. 24, 25 IRAK-1 in turn mediates the ubiquitination of TRAF6 and then activates TGF-b-activated kinase 1 (TAK1), which is required for NF-kB and mitogen-activated protein kinase (MAPK) activation induced by TLR ligands. 24, 26 Activated TAK1 phosphorylates IkB kinase (IKK) and MAPK kinase 6, culminating in the degradation of the NF-kB inhibitor, IkBa, resulting in translocation of NF-kB to the nucleus where it regulates gene expression. 24, 25, 27 NF-kB, which is primarily composed of p50 and p65 proteins and retained in the cytoplasm by the inhibitory subunitIkBa, plays a role in inflammation and immune modulation. 28 NF-kB can become activated by multiple inflammatory stimuli, including cytokine, endotoxin, ceramide and gamma irradiation. 29 Inflammatory stimuli-induced phosphorylation-dependent degradation of IkBa allows active NF-kB to translocate to the nucleus. Genes subsequently activated by NF-kB mediate inflammation and suppress apoptosis. [30] [31] [32] In addition, active MAPKs also participate the TLR signal transduction that initiates pro-inflammatory responses. 33, 34 There are three types of MAPKs in mammalian cells-ERK, JNK and p38, which can be activated simultaneously or independently. 35 Both p38 and ERK have been demonstrated to be critical for the induction of pro-inflammatory cytokines such as TNF-a and IL-1. 36, 37 Cytokines are important in inflammation, and thus much attention is paid to the research on cytokine-mediated inflammatory reactions in brucellosis. Studies have revealed that B. abortus can induce the production of pro-inflammatory cytokines such as TNF-a, IL-6, IL-12 and IL-1b from a variety of cell types. 5, [38] [39] [40] Brucella cell-surface protein 31 (BCSP31) is conserved in Brucella, but has no homology in human, mouse, or even many other pathogens, such as Mycobacteria tuberculosis, Listeria monocytogenes and Salmonella typhimurium. This molecule has many effects on vaccinology and diagnosis. [41] [42] [43] [44] [45] [46] BCSP31 can serve as a protective subunit vaccine in rodents. 41 Our group has constructed a combined DNA vaccine including BCSP31 and found that immunization of mice with this vaccine offers significant protection against B. abortus infection. 46, 47 However, the mechanism of how the innate immune system responds to BCSP31 is not well defined.
In this study, we used recombinant BCSP31 (rBCSP31) from B. abortus in a vaccine for mice and focused on its effects on macrophages. The results indicated that rBCSP31 induced cytokine secretion and upregulated antigen presentation using MHC-II, CD80 and CD86, which enhance the Th1 immune response including IL-2 and IFN-c secretion. During immune recognition, rBCSP31 interacted with TLR4 and TLR2 to transduce the activation signal, which elicited the activation of both NF-kB and MAPKs that control cytokine production.
MATERIALS AND METHODS
Mice and cell lines C57BL/6 mice were purchased from Vital River Company (Beijing, China). TLR2
2/2 and TLR4 2/2 mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). MyD88
mice were provided by the Model Animal Resource Center of Nanjing University (Nanjing, China). All mice were raised in the Animal Center of Peking University (Beijing, China). All animal experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee at Peking University. A mouse macrophage cell line, RAW264.7 and a human embryonic kidney cell line, HEK293, were originally obtained from the American Type Culture Collection (Manassas, VA, USA). HEK293-Vector (transfected with empty pEGFP-N3 plasmid), HEK293-TLR2 (transfected with pEGFP-N3-TLR2 plasmid) and HEK293-TLR4 (transfected with pEGFP-N3-TLR4 plasmid) stable cell lines were maintained in our laboratory. The mouse gene encoding TLR1 was cloned into the pEGFP-N3 plasmid and transiently transfected into HEK293 cells with polyethylenimine reagent (Sigma-Aldrich, St Louis, MO, USA). Cell lines were cultured in DMEM (Thermo Fisher Scientific, Waltham, MA, USA) containing 10% FBS (Gibco BRL, Gaithersburg, MD, USA), 100 U/ml penicillin and 100 mg/ml streptomycin. Primary cells were cultured in RPMI 1640 (Thermo Fisher Scientific) containing 10% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin at 37 uC in a humidified incubator containing 5% CO 2 .
Cloning, expression and purification of recombinant BCSP31 (rBCSP31) The gene encoding rBCSP31 was amplified using PCR based on the genomic DNA sequence of B. abortus. The PCR product was then cloned using the prokaryotic expression plasmid pET22b 1 (Novagen, Darmstadt, Germany) as described. 46 The soluble rBCSP31 was purified by affinity chromatography using His-Trap (GE Healthcare Bio-Science AB, Uppsala, Sweden) and dialyzed against PBS for use in subsequent testing of its ability to induce cytokine production by macrophages.
Measurement of cytokine levels
Cytokines were measured in supernatants of RAW264.7 cells, peritoneal macrophages and T lymphocytes using ELISA MAX Set Deluxe kits (Biolegend, San Diego, CA, USA) following the manufacturer's instructions. To inhibit MAPKs, RAW264.7 cells were pre-treated with an inhibitor of p38 (SB203580; 30 mM), ERK (PD98059; 50 mM) or JNK (JNK inhibitor II; 40 mM) for 30 min at 37 uC followed by stimulation with 5 mg/ml rBCSP31. To inhibit NF-kB, an NF-kB inhibitor (JSH-23; 50 mM) was added to cells 30 min before rBCSP31 stimulation. The inhibitors were purchased from SigmaAldrich. To detect the immunogenicity of rBCSP31, 50 mg/ml rBCSP31 was digested for 2 h at 37 uC with soluble proteinase K (PK; Genestar, Beijing, China) at 0.5 mg/ml followed by heating for 5 min at 95 uC to inactivate the enzyme.
RT-PCR and quantitative RT-PCR (QRT-PCR)
RAW246.7 cells (5310 5 per well) were treated with 0-5 mg/ml rBCSP31 or LPS (1 mg/ml) for 0.5 or 12 h. After treatment, the cell culture supernatant was removed, and the cells were washed twice with PBS. Trizol (Invitrogen, Carlsbad, CA, USA; 500 ml) was added to each well, incubated for 5 min at room temperature, vigorously mixed with 100 ml chloroform and centrifuged to separate the aqueous phase from the organic phase. Isopropanol was added to the aqueous phase (1 : 1), and samples were incubated at 220 uC for 2 h and centrifuged to precipitate the RNA. The precipitate was washed with 75% ethanol and dissolved in diethylpyrocarbonate-treated double-distilled water. First-strand cDNA was synthesized via reverse transcription using total RNA Transcript II reverse transcriptase (TransGen Biotech Company, Beijing, China). RT-PCR was carried out using EasyTaq PCR SuperMix (TransGen Biotech Company) in a C1000 Thermal Cycler (Bio-Rad Laboratories, Hercules, CA, USA) and the amplified target genes were visualized using DNA agarose gel electrophoresis with a Universal Hood II Gel Imager (Bio-Rad Laboratories). QRT-PCR was carried out using a TransStart Green qPCR SuperMix UDG kit (TransGen Biotech Company) in a CFX96 Real-Time System (Bio-Rad Laboratories). Quantitative analysis of transcription of target genes was carried out using the comparative threshold method with SYBR green as reported. 48 The housekeeping gene GAPDH was used as the internal standard. All primers were synthesized by Sangon (Shanghai, China), and their sequences are as follows:
GAPDH sense 59-CGGTGCTGAGTATGTCG-39 and antisense 59-TTCTGGGTGGCAGTGAT-39, TNF-a sense 59-GGT-GCCTATGTCTCAGCCTCTT-39 and antisense 59-GCCATA-GAACTGATGAGAGGGAG-39, IL-6 sense 59-TACCACTTC-ACAAGTCGGAGGC-39 and antisense 59-CTGCAAGTGCAT-CATCGTTGTTC-39, IL-12p40 sense 59-TTGAACTGGCGTT-GGAAGCACG-39 and antisense 59-CCACCTGTGAGTTCTT-CAAAGGC-39. Isolation of mouse peritoneal macrophages C57BL/6, TLR2 2/2 or TLR4 2/2 mice were killed with ether anesthesia and cervical dislocation. Cells were aseptically isolated and cultured as previously described. 13 Non-adherent cells were removed by washing twice with medium and then were treated with rBCSP31 (5 mg/ml), LPS (1 mg/ml) or peptidoglycans (PGNs; 10 mg/ml).
Isolation and differentiation of mouse bone marrow-derived macrophages (BMDMs) C57BL/6, TLR2 2/2 or TLR4 2/2 mice were killed, and intact femurs were aseptically dislocated from the hind legs. The bone marrow cells were flushed from the femurs with 15 ml RPMI 1640 without FBS. A single-cell suspension was prepared from the marrow plugs by repeated gentle passage through a needle. Cells were then centrifuged for 5 min at 600 g, and the pellet was resuspended in Red Blood Cell Lysis Buffer (155 mM NH 4 Cl, 10 mM KHCO 3 , 0.1 mM EDTA, pH 7.4, sterilized through a 0.22-mm filter) for 5 min at 37 uC to lyse the erythrocytes. The cells were washed twice in medium and resuspended in RPMI 1640 containing 20% supernatant from L929 cells, 10% FBS, 100 U/ml penicillin and 100 mg/ml streptomycin and incubated at 37 uC in 5% CO 2 . Medium was refreshed every 2 days without resuspending the cells. After 1 week of differentiation, cells were used for experimentation.
Cellular protein preparation and western blot analysis RAW264.7 cells or BMDMs were stimulated for various times and washed twice with cold PBS. The cells were lysed with cell lysis buffer (AidLab, Beijing, China) supplemented with a proteinase inhibitor cocktail and phosSTOP (Roche Molecular Biochemicals, Indianapolis, IN, USA) and centrifuged for 15 min at 4 uC at 12 000 g. Protein concentration was measured using the Bradford method. For subcellular localization analysis of NF-kB, cell pellets were processed using the NE-PER Nuclear and Cytoplasmic Extraction kit (Pierce, Rockford, IL, USA) following the manufacturer's instructions. Equal amounts of protein were resolved via SDS-PAGE and then transferred to an Immobilon-P membrane (Millipore, Bedford, MA, USA). After blocking with 5% non-fat milk or BSA in TBST (pH 7.4, 0.05% v/v Tween-20), each membrane was incubated overnight at 4 uC with a primary Ab: rabbit anti-ERK2 (sc-153), rabbit anti-p38 (sc-728), rabbit anti-NF-kB p65 (sc-109; Santa Cruz Biotechnology, Dallas, TX, USA), rabbit anti-histone H3 (9715), rabbit anti-phospho-ERK1/2 (9101), rabbit anti-phospho-p38 (9211), rabbit anti-JNK (9252), rabbit anti-phospho-JNK (9251), rabbit anti-IkKa (9242), rabbit anti-phospho-IkKa (S32; 2859; Cell Signaling Technology, Beverly, MA, USA) or mouse anti-b-actin (M20010; Abmart, Arlinton, MA, USA), according to the manufacturer's instructions. After washing with TBST, the membranes were incubated for 1-2 h at 37 uC with the appropriate HRP-conjugated anti-mouse IgG or anti-rabbit IgG secondary Ab (1 : 10 000; Santa Cruz Biotechnology) followed by detection with ECL (CWBIO, Beijing, China) and X-ray film (XAR5; Kodak, Rochester, NY, USA).
Pull-down assay
Lysates from cells transfected with HEK293-Vector, TLR2, TLR4 or TLR1 were prepared as described above. His-tagged rBCSP31 (50 mg) immobilized on His-Trap beads was incubated with 500 mg total cellular protein for 4 h at 4 uC in cell lysis buffer with gentle rotation. The beads were washed vigorously and boiled in 53 Laemmli buffer for 10 min. Pulled down proteins were detected with western blotting with rabbit anti-GFP (E022200; EarthOx, San Francisco, CA, USA).
TLR binding assay
Cell lines expressing HEK293 vector, HEK293-TLR2, HEK293-TLR4 or HEK293-TLR1 were seeded overnight on poly-Llysine-treated coverslips and then incubated for 30 min at 37 uC with rBCSP31 (5 mg/ml). The cells were washed with PBS, fixed for 15 min in 4% paraformaldehyde, and then stained with sequential 1-h incubations with mouse anti-His (Santa Cruz Biotechnology) and PE-conjugated goat antimouse IgG (BioLegend). Between each staining step, the cells were washed three times with PBS. After staining, the cells were mounted on slides using Mowiol solution (Sigma-Aldrich) containing 100 ng/ml DAPI and observed using a 363 oil objective on an Axiovert 200M microscope (Carl Zeiss, Inc., Munich, Germany). For flow cytometry, the cells were collected after staining, and 10 000 total events per sample were analyzed using a FACScan calibrator cytometer (BD Corporation, San Jose, CA, USA).
shRNA interference A lentivirus-based shRNA system, which was a kind gift from Dr Chen Zhang in Peking University, was used to functionally silence genes in RAW246.7 cells. To generate lentiviruses, 293T cells (5310 5 /well) were seeded in six-well culture plates and cotransfected with 1.5 mg pLKO.1-shRNA or mock vector together with the packing vectors (1 mg RRE, 1 mg Rev and 0.5 mg VSVG) using polyethylenimine reagent. Medium was refreshed 18 h after transfection. Supernatants were collected 48 h after transfection, filtered through a 0.45-mm membrane and used to infect cells. RAW264.7 cells (4310 5 /well) were seeded in six-well culture plates, infected with the supernatants in the presence of polybrene (8 mg/ml) and selected using puromycin (2 mg/ml) to generate stable transformants.
Subcellular localization of NF-kB RAW264.7 cells (2310 5 /well) were seeded in 12-well culture plates with glass cover slips, treated directly with rBCSP31 (5 mg/ml) for 0, 15, 30 or 60 min or after 30-min pre-treatment with the NF-kB inhibitor JSH-23 (50 mM) and washed twice with PBS. The cells then were fixed for 5 min on ice in cold methanol. To reduce background staining, the cells were incubated for 30 min in PBS containing 5% BSA before incubation with rabbit anti-NF-kB p65. After incubation for 1.5 h, the cells were washed and incubated with FITC-conjugated goat antirabbit IgG for 1 h at room temperature in the dark. The cells were washed and mounted on slides using Mowiol solution containing 100 ng/ml DAPI. NF-kB localization was observed using a Zeiss LSM 710 confocal microscope equipped with a 633, 1.4-numerical aperture, oil immersion objective (Carl Zeiss, Inc.).
Flow cytometry
RAW264.7 cells were incubated in 24-well plates (2310 5 cells/ well) with rBCSP31 (0 or 5 mg/ml) and IFN-c (0 or 20 ng/ml) (Peprotech, London, UK) for 12, 24 or 48 h and washed with cold PBS. Peritoneal macrophages were incubated in 24-well plates (2310 5 cells/well) with rBCSP31 (0 or 5 mg/ml) and IFNc (0 or 20 ng/ml) for 48 h and washed with cold PBS. The cells were stained with PE-CY5-conjugated anti-mouse MHC-II (eBioscience), FITC-conjugated anti-mouse CD86, R-phycoerythrin-conjugated anti-mouse CD80 (SouthernBiotech, Birmingham, AL, USA), or the corresponding isotype control Ab (Biolegend) in the dark for 1 h. The stained cells were then washed three times with PBS and fixed with 1% paraformaldehyde. Ten thousand cells were acquired on a FACScan calibrator cytometer, and data were analyzed using Summit software (DakoCytomation, Fort Collins, CO, USA).
Isolation of splenic lymphocytes
To obtain a large number of rBCSP31-specific CD4
1 T cells for an Ag processing assay, C57BL/6 mice were immunized every 3 weeks for a total of three times using a BCSP31 DNA vaccine. The vaccine consisted of a mixture of plasmid pJW4303-BCSP31 (100 mg) and adjuvant pJW4303-IL15 (50 mg), which was administered i.m. into the quadriceps muscle. The DNA used in the vaccine was purified using the Endo-free plasmid mega kit (Omega Bio-tek, Norcross, GA, USA) and diluted in saline to a final concentration of 1 mg/ml. Three weeks after the final immunization, the mice were euthanized with ether anesthesia and cervical dislocation. Splenic lymphocytes were isolated and cultured as previously described. 13 Ag processing and presentation RAW264.7 cells (2.5310 4 cells/well) were incubated in 96-well plates with rBCSP31 (0 or 5 mg/ml) and IFN-c (0 or 20 ng/ml) for 36 h at 37 uC. After replacing the medium, the cells were incubated with rBCSP31 (5 mg/ml) for 2 h to elicit Ag presentation. Cells were then washed with PBS and fixed for 20 min in 1% paraformaldehyde at room temperature. The rBCSP31 Agspecific CD4
1 T cells isolated from immunized mice were added at a density of 2310 5 cells/well, and the plates were cultured for 36 h at 37 uC. Supernatants were harvested, and the IL-2 concentration in each supernatant sample was measured using ELISA as described above.
Mouse vaccination and challenge C57BL/6, TLR2 2/2 and TLR4 2/2 mice (n57 per group) were immunized with three doses (14 days apart) of rBCSP31. Each mouse was subcutaneously injected with 200 ml PBS containing 30 mg rBCSP31 at two sites on the back (100 ml/site). Negative control mice were injected with 200 ml PBS. Positive control mice were vaccinated intraperitoneally with 5310 6 colonyforming units (CFU) of B. abortus strain A19 in 100 ml PBS at the time of the first and last vaccinations. To analyze cytokine production, three mice were sacrificed 3 weeks after the last vaccination, and peritoneal macrophages and splenic lymphocytes were isolated. Four weeks after the last vaccination, four mice from each group were challenged intraperitoneally with 6310 5 CFU of B. abortus strain 2308. Infected mice were sacrificed 2 weeks after the challenge. Spleens were removed, and the numbers of CFU were counted as reported. 46 
Statistical analysis
Results are presented as the mean6s.d. of triplicate samples. Statistical testing was conducted using the Student's t-test or ANOVA followed by Tukey's test using GraphPad Prism 5 (GraphPad Software, Inc., La Jolla, CA, USA). Protection results were evaluated using one-way ANOVA followed by Dunnett's test. For all tests, P,0.05 was considered statistically significant.
RESULTS
rBCSP31 elicits cytokine production from mouse macrophages in a TLR2-and TLR4-dependent manner After treatment with various concentrations of rBCSP31, cytokines secreted into the RAW264.7 cell culture supernatant were measured with ELISA, and the transcript levels of cytokines were measured with RT-PCR and QRT-PCR. rBCSP31 significantly increased the production of TNF-a, IL-6 and IL-12p40 at both the protein level (P,0.05, P,0.01 and P,0.001; Figure 1a ) and the transcript level (P,0.01 and P,0.001; Figure 1b ) in a dose-dependent manner. The effect was specific to rBCSP31, because proteinase K abrogated the rBCSP31-induced production of TNF-a, IL-6 and IL-12p40 (P,0.001; Figure 1a ). Heat-denatured rBCSP31 showed attenuated ability to induce the production of pro-inflammatory cytokines (P,0.01 and P,0.001; Figure 1a ), indicating that natural structure was important for the full effect of rBCSP31. In addition, polymyxin B did not attenuate the rBCSP31-induced TNF-a, IL-6 and IL-12p40 production but inhibited the LPSinduced production (Supplementary Figure 1) , indicating that the effects of rBCSP31 were not due to contamination with LPS. The rBCSP31 preparation from Escherichia coli showed high purity, as shown with SDS-PAGE and subsequent Coomassie staining and silver staining (Supplementary Figure 2) .
Next, we used C57BL/6, TLR2 2/2 and TLR4 2/2 mice to analyze whether TLR2 and TLR4 mediated the production of cytokines induced by rBCSP31. Peritoneal macrophages were isolated from C57BL/6, TLR2 2/2 and TLR4 2/2 mice and stimulated. Cytokine production was significantly lower in rBCSP31-stimulated macrophages from TLR2 2/2 and TLR4 2/2 mice compared to C57BL/6 mice (P,0.01 and P,0.001), indicating that the effects of rBCSP31 were dependent on TLR2 and TLR4 ( Figure 1c ). rBCSP31 is a ligand for mouse TLR2 and TLR4 Because rBCSP31 could stimulate cytokine secretion via TLR2 and TLR4, a pull-down experiment was performed to test the interaction between rBCSP31 and different TLRs. Western blots showed that immobilized rBCSP31 pulled down TLR2 and TLR4 but not TLR1 or the vector control ( Figure 2a ). Flow cytometry also showed that the percentage of HEK293-TLR2 and HEK293-TLR4 cells that bound rBCSP31 was significantly increased in a dose-dependent manner (P,0.01 and P,0.001; Figure 2b ). Immunofluorescence microscopy likewise showed strong anti-rBCSP31 fluorescence on the surface of HEK293-TLR2 and HEK293-TLR4 cells incubated with rBCSP31 but little fluorescence on HEK293-vector or HEK293-TLR1 cells (Figure 2c ). These results indicated that rBCSP31 interacts specifically and primarily with TLR2 and TLR4. Next, we determined whether the rBCSP31-TLR2 or -TLR4 interaction was dependent on an accessory molecule-CD14, which is required for LPS-TLR4 interactions. 49 Indeed, CD14 influenced the TLR2-and TLR4-dependent enhancing effect of rBCSP31 ( Supplementary Figure 3a and b) . However, IRS 2088 did not affect rBCSP31-induced cytokine production (Supplementary Figure 3c) . These data demonstrated that rBCSP31 stimulated cytokine secretion specifically via TLR2 and TLR4.
rBCSP31 activates MyD88-dependent and TRIF-dependent signaling pathways MyD88 is a major adapter molecule that is downstream of TLR2 and TLR4. Using C57BL/6 and MyD88 2/2 mice, we showed that rBCSP31 induced TNF-a, IL-6 and IL-12p40 production in murine macrophages from C57BL/6 mice, whereas rBCSP31-induced cytokine production in macrophages from MyD88 2/2 mice was remarkably reduced (P,0.05, P,0.01 and P,0.001), which indicated use of a MyD88-dependent pathway (Figure 3a) . TLR4 can also recruit another adapter molecule, TRIF, to transduce an activation signal. Here, we used shRNA to silence the transcription of TRIF in RAW264.7 cells and then analyzed production of TNF-a, IL-6 and IL-12p40 induced by rBCSP31. The result showed that rBCSP31-induced cytokine production in TRIF-silenced cells was lower than in control cells (P,0.001; Figure 3b ), indicating that a TRIF-dependent signaling pathway was also activated by rBCSP31 treatment.
rBCSP31 induces translocation of NF-kB subunits to the nucleus in mouse macrophages NF-kB is a pivotal transcription factor that plays a role in the production of pro-inflammatory cytokines and the expression of costimulatory molecules. 50, 51 The promoters of IL-12p40, 52 TNF-a 53 and IL-6 54 contain NF-kB binding sites, and active NF-kB transcription factors mediate the transcription of these genes by binding to these sites. Therefore, the effects of rBCSP31 on activation and translocation of NF-kB were examined. The observation by confocal microscopy revealed the localization of NF-kB p65 to the nucleus in rBCSP31-treated cells. After 15 min of stimulation with rBCSP31, NF-kB p65 was found to translocate into the nuclei, but the level decreased after 1 h of stimulation. In control cells, NF-kB p65 was located primarily in the cytoplasm (Figure 4a ). Western blotting also showed that rBCSP31 induced the nuclear translocation of nuclear NF-kB and the concomitant phosphorylation and degradation of IkBa in RAW264.7 cells (Figure 4b) .
Because rBCSP31 promoted NF-kB activation by inducing its nuclear translocation, we next determined whether TLR2 or TLR4 was necessary for NF-kB activation. Western blotting showed that rBCSP31 induced phosphorylation and degradation of IkBa. The nuclear translocation of NF-kB was impaired in BMDMs from TLR2 2/2 and TLR4 2/2 mice compared with The fold increases in mRNA levels were relative to induction by medium alone, which was arbitrarily set to 1. The GAPDH mRNA level was used as an internal standard. QRT-PCR results were expressed as the means6s.d. of triplicate independent samples. (c) Peritoneal macrophages from C57BL/6, TLR2 2/2 or TLR4 2/2 mice were treated with rBCSP31 (5 mg/ml), LPS (1 mg/ml) or PGN (10 mg/ml). TNF-a, IL-6 and IL-12p40 levels in the supernatants were measured with ELISA. Data are representative of three different experiments. Significant differences were calculated using the Student's t-test between different treatments and medium or as labeled (*P,0.05; **P,0.01; ***P,0.001). LPS, lipopolysaccharide; PGN, peptidoglycan; PK, proteinase K; rBCSP31, recombinant Brucella cell-surface protein 31; QRT-PCR, quantitative RT-PCR; TLR, Toll-like receptor.
BMDMs from C57BL/6 mice. Degradation of IkBa was not detected in BMDMs from TLR4 2/2 mice, indicating that the effects of rBCSP31 were dependent on TLR2 and TLR4 (Figure 4c) .
To establish the relative contribution of NF-kB activity to the pro-inflammatory responses initiated by rBCSP31, we treated cells with a specific inhibitor, JSH-23, which blocks nuclear translocation of NF-kB (Figure 4d ). rBCSP31-induced production of pro-inflammatory cytokines was examined using ELISA. TNF-a production was significantly blocked upon JSH-23 treatment (P,0.001, ,60% inhibition with 5 mg/ml rBCSP31), IL-6 production was almost entirely blocked (P,0.001), but IL12p40 was not significantly blocked (Figure 4e) , implicating NF-kB as a key component of TNF-a and IL-6 responses.
rBCSP31 induces phosphorylation of MAPKs through TLR2 or TLR4 signaling Because MAPKs are also critical factors that are involved in cellular responses to inflammatory stimuli, we then examined the activation of MAPKs in response to rBCSP31. MAPK phosphorylation is a critical prerequisite of its activation and is a well-defined indicator of the enzymatic activity level. 55 Western blotting was used to examine the phosphorylation of p38, JNK and ERK1/2 in RAW264.7 cells at different time points after stimulation with rBCSP31 (5 mg/ml). Strong phosphorylation of p38, JNK and ERK1/2 was observed after 10-60 min of stimulation. Little phosphorylation was observed in untreated cells. Phosphorylation peaked after 30 min of stimulation with rBCSP31 ( Figure 5a ). We also found that SB203580 (inhibits p38 MAPK), PD98059 (inhibits ERK) or JNK inhibitor II abolished rBCSP31-induced phosphorylation of p38, JNK and ERK1/2, respectively (Figure 5b ). These results confirmed our data regarding the role of phosphorylation of MAPKs induced by rBCSP31.
We next examined whether rBCSP31 activated the p38, JNK and ERK1/2 via TLR2 or TLR4. Western blotting was used to measure rBCSP31-induced phosphorylation levels of p38, JNK and ERK1/2 in BMDMs isolated from C57BL/6, TLR2 2/2 or TLR4 2/2 mice. As shown in Figure 5c -e, the rBCSP31-mediated phosphorylation of p38 was reduced in TLR2 2/2 mice after 10 min, whereas phosphorylation of p38 was not detected in TLR4 2/2 mice. The rBCSP31-mediated phosphorylation of JNK was attenuated in BMDMs from TLR2 2/2 and TLR4 2/2 mice at 10 min. In contrast, the rBCSP31-induced phosphorylation of ERK1/2 was attenuated in BMDMs from TLR4 2/2 but not TLR2 2/2 mice. Therefore, the phosphorylation of MAPKs in response to rBCSP31 was dependent on TLR2 and TLR4, with TLR4 being crucial. rBCSP31-induced cytokine production depends primarily on the activation of p38-and JNK-dependent signaling ELISA was used to examine rBCSP31-induced production of TNF-a, IL-6 and IL-12p40 in RAW264.7 cells pre-treated with or without SB203580, PD98059, or JNK inhibitor II. TNF-a production was significantly blocked by JNK inhibitor II (P,0.001, ,90% inhibition with 5 mg/ml rBCSP31) and partially by SB203580 (P,0.001, ,30% inhibition with 5 mg/ml rBCSP31). The production of IL-6 and IL-12p40 was also significantly blocked by JNK inhibitor II (P,0.01 and P,0.001, ,95% inhibition) and attenuated by SB203580 (about 50-80% inhibition). But the production of all three cytokines was not inhibited by PD98059 (Figure 6a ). When the transcript levels of TNF-a, IL-6 and IL-12p40 were examined using QRT-PCR, similar results were obtained (Figure 6b ).
rBCSP31 enhances IFN-c-induced expression of MHC-II in mouse macrophages in a TLR2-and TLR4-mediated manner
To investigate the effect of rBCSP31 on MHC-II expression, RAW264.7 cells were stimulated with rBCSP31 for 12, 24 or 48 h with or without IFN-c (20 ng/ml) and the expression of MHC-II was examined using flow cytometry. MHC-II expression was low in RAW264.7 cells cultured in medium for 0-48 h (Figure 7a and e). Incubation with IFN-c resulted in a twofold increase in MHC-II expression at 24-48 h, and incubation with rBCSP31 resulted in a twofold increase in MHC-II expression at 24 h and a threefold increase at 48 h. When cells were treated with both rBCSP31 and IFN-c, MHC-II expression was significantly increased after 24 h (P,0.01) and culminated at 48 h (Figure 7a-e) . In addition, because changes in the expression of cell-surface costimulatory molecules are involved in Ag presentation and T-cell stimulation, 56 RAW264.7 cells were incubated for 48 h with rBCSP31 alone or with IFN-c, and expression of surface markers was evaluated with flow cytometry. Incubation of cells with rBCSP31 alone or rBCSP31 and IFN-c significantly increased the expression of the cell-surface costimulatory molecules CD80 and CD86 after 48 h (P,0.001; Figure 7f h), suggesting that rBCSP31 can activate the innate immune response by upregulating co-stimulatory molecules.
We also detected rBCSP31-induced upregulation of the expression of MHC-II, CD80 and CD86 in peritoneal macrophages from C57BL/6, TLR2 2/2 and TLR4 2/2 mice. The cells were incubated with IFN-c, rBCSP31 or both of them for 48 h, mice or C57BL/6 mice were treated with rBCSP31 (5 mg/ml), LPS (1 mg/ml) or PGN (10 mg/ml). TNF-a, IL-6 and IL-12p40 levels in the supernatant were measured with ELISA. (b) Control RAW264.7 cells or cells stably expressing a shRNA against TRIF or mock vector were treated with rBCSP31 (5 mg/ml), LPS (1 mg/ml) or PGN (10 mg/ml). Cytokine production was measured with ELISA. Data represent three independent experiments. Significant differences were calculated between control and shRNA interference for each treatment using the Student's t-test (***P,0.001). LPS, lipopolysaccharide; MyD88, myeloid differentiation factor 88; PGN, peptidoglycan; rBCSP31, recombinant Brucella cell-surface protein 31; TRIF, Toll-IL-1 resistance domain-containing adaptor-inducing IFN-b.
and flow cytometry was used to examine expression of the above molecules. rBCSP31 enhanced MHC-II, CD80 and CD86 expression in peritoneal macrophages from C57BL/6 mice. However, the expression of MHC-II, CD80 and CD86 was significantly lower in TLR2 2/2 and TLR4 2/2 mice than in C57BL/6 mice (P,0.05, P,0.01 and P,0.001; Figure 7i-k) , suggesting a role for TLR2 and TLR4 in rBCSP31-mediated enhanced expression of MHC-II and costimulatory molecules. Figure 4 rBCSP31 affects NF-kB subcellular localization and activity to regulate TNF-a and IL-6 production. Confocal microscopy (a, left, original magnification, 363, 1.4-numerical aperture, oil immersion objective) and western blotting (b) were used to determine the effects of rBCSP31 on the translocation of NF-kB from the cytoplasm to the nucleus in RAW264.7 cells. Histogram represents relative nuclear FITC fluorescence (a, right). In addition, total IkBa and phosphorylated IkBa levels in the cytoplasmic extracts were detected with western blotting using anti-IkBa and antiphospho-IkBa (b). (c) Western blotting was used to determine the effects of rBCSP31 on the translocation of NF-kB, total IkBa and phosphorylated IkBa levels in peritoneal macrophages from C57BL/6, TLR2 2/2 or TLR4 2/2 mice after treatment with medium alone or rBCSP31 (5 mg/ml) for the indicated times (0-60 min). (d) RAW264.7 cells were pre-treated with or without the NF-kB-specific inhibitor JSH-23 for 30 min, and confocal microscopy (original magnification, 363, 1.4-numerical aperture, oil immersion objective) was used to determine the translocation of NF-kB after incubation with medium alone or stimulation with rBCSP31 (5 mg/ml). (e) Effect of NF-kB inhibition on proinflammatory cytokine secretion. Macrophages were pre-treated with or without JSH-23 for 30 min followed by incubation with medium alone or stimulation with rBCSP31 (5 mg/ ml). Concentrations of TNF-a, IL-6 and IL-12 in the supernatant were measured with ELISA. Data are expressed as the mean6s.d. from three separate experiments. Significant differences were calculated between rBCSP31 (5 mg/ml) treatment with or without JSH-23 pre-treatment using the Student's t-test (*P,0.05; ***P,0.001; n.s., not significant). rBCSP31, recombinant Brucella cell-surface protein 31; TLR, Toll-like receptor.
rBCSP31 enhances the ability of macrophages to present rBCSP31 peptide to CD4 1 T cells To determine if the increase in MHC-II expression influences the presentation of rBCSP31-derived peptides to CD4 1 T cells by mouse macrophages, rBCSP31-specific CD4 1 T cells were isolated from mice vaccinated with pJW4303-BCSP31 plasmid. IL-2 concentrations produced by specific CD4
1 T cells are proportional to the number of specific MHC-II-peptide complexes recognized by the TCR. 57 rBCSP31-specific CD4 1 T cells were incubated for 36 h with RAW264.7 presentation cells pretreated with IFN-c, rBCSP31, or rBCSP31 plus IFN-c, and IL-2 concentrations in the supernatant were measured using ELISA. Treatment with IFN-c or rBCSP31 partially enhanced MHC-II presentation of rBCSP31 peptide to CD4 1 T cells, as reflected by increased IL-2 levels. The ability of macrophages to present rBCSP31 peptide was further enhanced after treatment with both rBCSP31 and IFN-c (P,0.05). In addition, the ability to recognize MHC-II-peptide complexes presented by RAW264.7 cells was not observed in CD4 1 T cells from TLR2 2/2 and TLR4 2/2 mice (P,0.01; Figure 8 ).
Mice vaccinated with rBCSP31 show an induced Th1 response that is TLR2-and TLR4-dependent IFN-c and IL-2 are essential cytokines secreted by CD4 1 T cells. CD4
1 T cells from rBCSP31-immunized C57BL/6, TLR2
2/2 and TLR4 2/2 mice were isolated and stimulated with rBCSP31 (5 mg/ml) for 48 h. IFN-c and IL-2 levels in the supernatants were detected with ELISA. rBCSP31-immunized C57BL/6 mice showed induction of a significant level of IFN-c and IL-2 in CD4
1 T cells (P,0.001), whereas the levels of IFN-c and IL-2 in CD4
1 T cells from immunized TLR2 2/2 and TLR4 2/2 mice were remarkably attenuated (P,0.05 and P,0.001; Figure 9a and b). On the contrary, IL-4, which may promote Th2-type immune response switching, was detected at low levels in T Figure 5 rBCSP31 induces the phosphorylation of p38, ERK and JNK through TLR2 and TLR4. (a) RAW264.7 cells were incubated with rBCSP31 (5 mg/ml) for the indicated times (0-120 min) and cell lysates were analyzed with western blotting using anti-phospho-p38 (p-p38), anti-phospho-JNK (p-JNK) or anti-phospho-ERK1/2 (p-ERK1/2) to examine the phosphorylation/activation of p38, JNK and ERK1/2. Each specific Ab for the unphosphorylated kinase was used as a loading control. (b) RAW264.7 cells were pre-treated for 30 min with MAPK inhibitors SB203580 (30 mM), JNK inhibitor II (40 mM) or PD98059 (50 mM) and then stimulated with rBCSP31 (5 mg/ml) for 30 min. After incubation, cell lysates were analyzed for phosphorylation of p38, JNK and ERK1/2 with western blotting. Phosphorylation of p38 (c), JNK (d) and ERK1/2 (e) in bone marrow-derived macrophages from C57BL/6 (wild type, WT), TLR2 2/2 or TLR4 2/2 mice after treatment with medium alone or rBCSP31 (5 mg/ml) for the indicated times (0-120 min) was detected with western blotting. Data are representative of three independent experiments. Ab, antibody; MAPK, mitogenactivated protein kinase; rBCSP31, recombinant Brucella cell-surface protein 31; TLR, Toll-like receptor.
cells from all mice (Figure 9c ). TNF-a is an essential cytokine released by macrophages. In this study, we showed that macrophages from C57BL/6 mice immunized with rBCSP31 produced a significantly higher level of TNF-a than the respective medium (P,0.001); however, the amount secreted by TLR2 2/2 cells was only about half (P,0.05), and the amount secreted by TLR4 2/2 cells was only about one-third compared to the amount produced by macrophages from C57BL/6 mice (P,0.001; Figure 9d ). IL-12 is also a key cytokine produced mainly by macrophages upon pathogen recognition that helps establish the Th1 response. In response to rBCSP31 stimulation, C57BL/6 macrophages secreted significantly higher levels of IL-12p40 than TLR4 2/2 or TLR2 2/2 macrophages (P,0.01 and P,0.001; Figure 9e ). However, the amount of IL-12p40 secreted was reduced by half in TLR2 2/2 cells and by 90% in TLR4 2/2 cells (Figure 9e ). These results indicate that rBCSP31 vaccination enhances the Th1 response and is TLR2-and TLR4-dependent.
Role of TLR2 and TLR4 in rBCSP31 vaccine protection against B. abortus infection To determine the contribution of TLR2 and TLR4 in rBCSP31 vaccination, protection experiments were carried out in mice by challenging immunized mice with intraperitoneal injection of B. abortus 2308. The levels of infection were evaluated by measuring CFU in the spleen of C57BL/6, TLR2 2/2 and TLR4 2/2 mice 2 weeks after B. abortus infection (Table 1) . rBCSP31-immunized C57BL/6 mice showed significant protection compared to C57BL/6 mice immunized with PBS (1.10 log units of protection; P,0.01; n54). In contrast, rBCSP31-immunized TLR2 2/2 and TLR4 2/2 mice showed no statistically significant protection against B. abortus infection (0.28 or 0.02 log units of protection; P.0.05 vs. PBS; n54). In addition, rBCSP31-immunized C57BL/6 mice showed significantly higher levels of protection than rBCSP31-immunized TLR2 2/2 mice or rBCSP31-immunized TLR4 2/2 mice. Thus, rBCSP31 elicits a significant level of protection against B. abortus infection, and The fold increases in the mRNA level were relative to transcription induced by medium, which was arbitrarily set to 1. The GAPDH mRNA level was used as an internal standard. QRT-PCR results were expressed as means6s.d. of triplicate independent samples. Data are representative of three different experiments. Significant differences were calculated between rBCSP31 (5 mg/ml) treatment with or without each inhibitor using the Student's t-test (*P,0.05; **P,0.01; ***P,0.001). MAPK, mitogen-activated protein kinase; rBCSP31, recombinant Brucella cell-surface protein 31; QRT-PCR, quantitative RT-PCR; TLR, Toll-like receptor. the protection is TLR2-and TLR4-dependent. These in vivo findings reinforce the important role of TLR2 and TLR4 in priming the protective immune response against rBCSP31 and indicate that rBCSP31 has conserved intrinsic immunogenicity that activates the innate immune system and induces a protective response through its interaction with TLR2 and TLR4.
DISCUSSION
Upon recognizing the molecular pattern presented by invading pathogens, TLRs activate components of the innate and adaptive immune systems to restrict pathogen spread. 7, 16, 22 We show that rBCSP31 induced activation of macrophages as seen by increased production of pro-inflammatory cytokines with concomitant upregulation of costimulatory and Ag-presenting molecules. Further, macrophages that matured in the presence of rBCSP31 were functionally competent as they induced cytokine secretion from CD4
1 T cells, thus implicating the immunopotency of rBCSP31. We demonstrate that, indeed, rBCSP31 induced pro-inflammatory cytokines through a TLR2-and TLR4-dependent pathway, because the production of those cytokines was lower in macrophages from TLR2 2/2 or TLR4 2/2 mice than from C57BL/6 mice. rBCSP31 interacted more strongly with HEK293-TLR2 cells and HEK293-TLR4 cells than to HEK293-TLR1 or HEK293-vector cells and was able to pull down TLR2 and TLR4 but not TLR1 or the vector control. In addition, rBCSP31 maintained stimulating activity when cocultured with polymyxin B (Supplementary Figure 1) and lost its activity after digestion with proteinase K. These results indicated that the stimulating effect was not due to LPS contamination but rather a specific property of the rBCSP31 protein. These results demonstrate that rBCSP31 was a potent agonist for both TLR2 and TLR4. The TLR2 and TLR4 signaling pathways play critical roles in cellular responses 2/2 and TLR4 2/2 mice and stimulated with rBCSP31 (5 mg/ml). Supernatants were harvested and assayed for TNF-a (d) and IL12p40 (e) with ELISA. Data are expressed as the mean6s.d. and represent three independent experiments. Significant differences were calculated between treatment and medium alone (**P,0.01; ***P,0.001) or among C57BL/6, TLR2 2/2 and TLR4 2/2 mice ( # P,0.05; ## P,0.01; ### P,0.001) with ANOVA followed by Tukey's test. rBCSP31, recombinant Brucella cell-surface protein 31; TLR, Toll-like receptor. to multiple microbial species. Their extracellular domain contains leucine-rich repeats, motifs that are generally involved in protein-protein interactions, 58 and so the fact that rBCSP31 is a agonist for TLR2 and TLR4 is understandable.
During stimulation, we found that rBCSP31-induced cytokine production was MyD88 dependent and TRIF dependent. Based on the cell signaling initiated upon TLR activation, MyD88 plays a pivotal role in the innate immune response against pathogens. In fact, MyD88 2/2 mice inefficiently control B. abortus infection, and the production of inflammatory cytokines by macrophages from these mice is completely abrogated. 59 The susceptibility of MyD88 2/2 mice to B. abortus infection is further correlated with impaired dendritic cell (DC) maturation and the absence of IL-12 synthesis. 60 We also found that rBCSP31 induced IFN-b production (Supplementary Figure 4) , which indicated the activation of the TRIF-dependent signaling pathway. TRIF is important for controlling DNA viruses such as VACV and CMV, 25 but is not involved in the host control of B. abortus infection. 61, 62 However, our result demonstrated that signaling through TRIF may participate in full production of inflammatory cytokines by macrophages after stimulation with rBCSP31.
IRAK-4 was phosphorylated after rBCSP31 treatment (Supplementary Figure 5a) , demonstrating that rBCSP31 induced IRAK-4 kinase activity, a component of the MyD88 pathway. IRAK-4 serine/threonine kinase phosphorylation is involved in the induction of NF-kB by LPS via the MyD88-dependent pathway. 63 IRAK-4 is correlated with efficient clearance of B. abortus in mice but not at later phases of infection. 64 
Similar to MyD88
2/2 mice, macrophages and DCs derived from IRAK-4 2/2 mice are unable to produce inflammatory cytokines in response to B. abortus. 65 The central role attributed to MyD88 and IRAK-4 proteins suggests the participation of TLRs during the control of B. abortus infection.
TAK1 functions as an upstream signaling mediator for both NF-kB and MAPK activation during TLR engagement in different immune cell types including macrophages. 66 A recent report demonstrated that TAK1 directly regulates JNK and p38 activity and ERK activity via IKKb. 67 Our results showed significant induction of TAK1 and IKK phosphorylation and the ubiquitination of TRAF6 in rBCSP31-treated macrophages ( Supplementary Figure 5b and c) . Taken together, our findings suggest that TAK1, in response to rBCSP31 during MyD88 signaling, may be responsible for both downstream MAPK and NF-kB pathways.
TLR2 and TLR4 activate a common signaling pathway that results in the activation of NF-kB and MAPKs such as ERK, p38 and JNK. 68, 69 Our results demonstrate that p38, ERK and JNK were rapidly phosphorylated in response to rBCSP31. A critical importance of p38 activity has been demonstrated in LPSinduced production of TNF-a and IL-1 by monocytes. 37 rBCSP31-induced production of TNF-a, IL-6 and IL-12p40 was drastically attenuated by a p38 inhibitor and a JNK inhibitor. The present results indicate that the p38 and JNK pathways are critical in the production of cytokines by rBCSP31-stimulated macrophages. Furthermore, in this case, NF-kB activation had a minimal effect on the production of IL-12p40, but p38 and JNK activation was necessary for rBCSP31-induced production of IL12p40. In addition, inhibition of rBCSP31-triggered ERK1/2 phosphorylation led to a significant increase in IL-12p40. These data also agree with a previous report indicating that p38 inhibitors temper IL-12p40 responses, whereas an ERK1/2 inhibitor significantly increases IL-12p40 in heat-killed B. abortus-stimulated DCs. 70 Taken together, these findings suggest that rBCSP31 may activate several innate immune signaling pathways, culminating in cytokine production. In addition, we observed that the phosphorylation of MAPK in response to rBCSP31 is mediated primarily by TLR2 and TLR4. Such selective use of the most important members of TLR signaling led us to hypothesize that the different sensitivities of upstream components regulated macrophage responses to rBCSP31. NF-kB is the primary transcription factor activated in TLR signaling, and it works as dimers formed by the interactions of two of the five Rel family proteins. 68 Inhibition of NF-kB A shift in NF-kB subunits from p50-p65 to p50 homodimers is associated with the resolution of inflammation, indicating that NF-kB may also resolve inflammation. 72, 73 Our results indicated that rBCSP31 increased the amount of p65 in the nucleus; this effect may then lead to increased MHC-II expression. Recently, the phosphorylation and acetylation of p65 was shown to be primarily important in DNA binding and trans-activation of NF-kB. [74] [75] [76] IKK has been shown to phosphorylate p65, 76,77 so rBCSP31 may induce p65 phosphorylation by activating IKKb. Meanwhile, IKKb was indeed activated via phosphorylation by rBCSP31 in our studies (Supplementary Figure 5d) .
As the activation of macrophages is critical in the priming of the adaptive immune response, we evaluated the ability of rBCSP31 to activate antigen-presentation. Our results indicated that rBCSP31 activates macrophages as shown by upregulated expression of MHC-II, CD80 and CD86 molecules on the macrophage cell surface.
The current results demonstrated that after 24 h or 48 h incubation, rBCSP31 enhanced IFN-c -induced MHC-II expression in RAW264.7 cells and thereby enhanced the ability of macrophages to present rBCSP31 peptide to specific CD4 1 T cells. This phenomenon is reflected in our observation of an increase in IL-2 production and the ability to recognize MHC-II-peptide complexes presented by RAW264.7 that was abolished in CD4
1 T cells from TLR2 2/2 and TLR4 2/2 mice compared with those from C57BL/6 mice. In addition, the ability to induce the expression of MHC-II, CD80 and CD86 was reduced in peritoneal macrophages from TLR2 2/2 or TLR4 2/2 mice. The effect of rBCSP31 on IL-2 production was blocked or attenuated in TLR2 2/2 or TLR4 2/2 mice, which indicates that the effects were mediated by the TLR2 and TLR4 signaling pathway. During the primary immune response, Ag-activated CD4 1 T cells release IL-2, and this cytokine is believed to play a role in increasing the antigenic sensitivity and expression of effector cytokines to enhance memory/effector function during secondary immune responses. 78 In previous studies, single Brucella antigens expressed in E. coli have been shown to induce appropriate innate immune responses and confer protection. Oral immunization with recombinant choloylglycine hydrolase of B. abortus mixed with cholera toxin provides 0.98 log units of protection against B. abortus 2308 infection in BALB/c mice. 79 Unlipidated outer membrane protein 16 of B. abortus has been reported to induce TLR4-dependent production of proinflammatory cytokines and confer 1.15 log units of protection against B. abortus 2308 infection in C57BL/6 mice. 80 Similarly, unlipidated outer membrane protein 19 of B. abortus induces a Th17 immune response and confers 1.12 log units of protection against B. abortus 2308 infection in C57BL/6 mice that is independent of TLR4. 81 Our result indicates that rBCSP31 vaccination provides a similar level of protection (1.10 log units of protection) against B. abortus to these single antigens expressed in E. coli. Our results showed that vaccination with rBCSP31 provided a higher level of protection against B. abortus infection in C57BL/ 6micecomparedwithTLR2 2/2 andTLR4 2/2 mice,demonstrating that TLR2 and TLR4 function as important molecules in the rBCSP31-triggered protective immune response.
Evaluation of the cellular immune responses of immunized mice indicated that rBCSP31 immunization induces a specific Th1 response in vitro as well as in vivo. This cellular Th1-specific response may be responsible for the elicited protection against Brucella infection because IFN-c plays a central role in protective responses against Brucella. [82] [83] [84] Indeed, IFN-cactivated macrophages are more capable of killing and inhibiting the intracellular microbial pathogens. 85 In order to enter and survive inside the infected host, pathogenic bacteria have developed various strategies during evolution. Hence, in order to recognize and fight against most of these pathogens, host immune system has prepared varieties of mechanisms. At the beginning of infection, innate immune system recognizes bacterial components to elicit a host protective response. 23 Different groups have investigated the contribution of TLRs in the host resistance to B. abortus infection. Studies using live B. abortus, 59 heat-killed B. abortus 40 or Brucella lipoproteins 86 demonstrated a role for TLRs. Indeed, the production of IL-12 is TLR2-dependent in heat-killed B. abortus-stimulated DCs. 60, 87 TLR4 mutant mice are more susceptible to infection with B. abortus S2308 strain than normal mice. 88 Moreover, the replication of B. abortus S19 strain and S2308 strain in vivo has also been demonstrated to be TLR4-independent. 89 Interestingly, Pei et al. 90 have demonstrated that TLR4 is involved in the internalization of smooth B. abortus in macrophages. 90 Of note, a recent study using unlipidated outer membrane protein 16 of B. abortus indicated that the production of pro-inflammatory cytokines induced by this unlipidated protein is TLR4-dependent. 80 In our study, high levels of antigen-specific Th1-type cytokines such as IFN-c and IL-2 and high levels of protection against B. abortus infection were observed in wild-type mice vaccinated with the rBCSP31 vaccine compared with these parameters in TLR2 2/2 and TLR4 2/2 mice. Furthermore, macrophages from immunized wild-type mice produced significantly higher levels of IL-12 than those from TLR2 2/2 and TLR4 2/2 mice. Studies by Huang et al. 91 demonstrated that DCs produce more IL-12 than macrophages. Although we did not perform an experiment with DCs, we believe that both DCs and macrophages will exhibit MHC-II expression and antigen presentation in our animal experiment because they induced higher levels of IL-12. Taken together, our results indicate that rBCSP31 is a TLR2 and TLR4 agonist that induces the production of cytokines by macrophages, upregulates macrophage function, and induces a protective Th1 immune response.
Finally, this report shows that rBCSP31 is a new bacterial pathogen-associated molecular pattern and a very promising component for vaccine against systemic brucellosis that signals through TLR2 and TLR4, activates macrophages, and induces the Th1 immune response. This study also unveiled a mechanism of the vaccine against brucellosis.
